Mechanistically, our WES data (Fig. 2) suggest that functional loss of the BRCA pathway may accelerate the loss of heterozygosity (LOH) at Trp53. In all mammary tumors tested, full p53 inactivation was caused by a complete loss of the wt allele rather than mutating it. Here, TP53 is linked to breast cancer.